News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Myeloma Paper of the Day, March 30th, suggested by Robert Orlowski
Mar 30, 2025, 13:32

Myeloma Paper of the Day, March 30th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Flatiron health record analysis comparing carfilzomib dosing in relapsed/refractory myeloma finds no support for improved outcomes with 2x weekly dosing; K56-1x may best balance efficacy, safety and avoidance of time toxicity.”

“Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis”

Authors: Sharlene Dong, Rahul Banerjee, Adeel M. Khan, Mengru Wang, Xiaoliang Wang, Adam Sperling, Larry Anderson Jr, Vincent Rajkumar, Gurbakhash Kaur et al.

Myeloma Paper of the Day, March 30th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

Adam Sperling Adeel M. Khan cancer Gurbakhash Kaur Larry Anderson Jr Mengru Wang multiple myeloma Myeloma Paper of the Day OncoDaily Oncology Rahul Banerjee Relapsed or Refractory Multiple Myeloma Robert Orlowski RRMM Sharlene Dong Vincent Rajkumar Xiaoliang Wang
Special Coverage
Blog
May 10, 2025, 14:36
Abdulla Alzibdeh: Tumor-Directed SBRT May Enhance Outcomes in LA-NSCLC on Durvalumab
Blog
May 10, 2025, 14:23
GEC-ESTRO Urology: Hathal Haddad Highlights Updates on Urological Cancer Brachytherapy
Blog
May 10, 2025, 14:14
Cizzle Bio Backs ALA’s Call for Broader Insurance Coverage of Biomarker Testing
Blog
May 10, 2025, 14:11
Cancer Awareness and Research Impact Group Launches on World Ovarian Cancer Day
Blog
May 10, 2025, 13:57
David Tougeron Introduces ENGIC – A New European Network for GI Cancers
Blog
May 10, 2025, 13:57
Jasmine Kamboj: We Need to Oppose Any Legislation that Would Reduce Federal Support for Medicaid
Blog
May 10, 2025, 13:48
Catherine Alix-Panabières: We’re Thrilled to Launch the 3rd General Assembly of the GUIDE.MRD IHI Project
Blog
May 10, 2025, 13:02
Danny Burke Shared ecancer’s Free Global Oncology E-Learning on Myelofibrosis and More
Blog
May 10, 2025, 12:49
Guru Sonpavde: New Study on Early Dynamics of Atezolizumab Resistance in Systemic Immunotherapy for Bladder Cancer
Blog
May 10, 2025, 11:51
Hathal Haddad: Celebrating Ina Jürgenliemk-Schulz on receiving the Iridium-192 Award at ESTRO 2025
Blog
May 10, 2025, 11:41
Patrick Hwu: Debut episode of The ImmunoVerse podcast with legendary Steven Rosenberg of the NCI
Blog
May 10, 2025, 11:04
Registrations Are Now Open for the 2025 Barcelona Biomed conference - Origins, Models and Therapies in Childhood Cancer